BioArctic says Q2 Leqembi sales total JPY 29.3 billion, generating SEK 179 million royalty
BIIB•Upcoming quarterly report
BioArctic scheduled its Q2 2026 report for Aug. 26, 2026 at 08:00 CEST.
Preliminary Q2 Leqembi sales and royalty
BioArctic flagged preliminary Q2 2026 global Leqembi sales of JPY 29.3 billion, based on partner reporting.
Royalty to BioArctic totaled SEK 179 million, up about 10% versus Q2 2025.
Year-on-year comparison adjusted for China stocking
Q2 2025 included a one-time China stockpiling effect of about JPY 5.3 billion; excluding it, Q2 2026 royalty rose about 43% year on year.
